Loading...
 
Toggle Health Problems and D

There are 2 concurrent pandemics – COVID-19 and Vitamin D deficiency – May 13, 2020


Br J Nutr. 2020 May 12;1-20. doi: 10.1017/S0007114520001749
Murat Kara 1, Timur Ekiz 2 timurekiz at gmail.com, Vincenzo Ricci 3, Özgür Kara 4, Ke-Vin Chang, Levent Özçakar 1
 Download the PDF from VitaminDWiki

Image

Image

World Health Organization announced the novel coronavirus disease (COVID-19) outbreak to be a global pandemic. The distribution of community outbreaks shows seasonal patterns along certain latitude, temperature, and humidity i.e. similar to the behavior of seasonal viral respiratory tract infections. COVID-19 displays significant spread in northern midlatitude countries with an average temperature of 5-11 °C and low humidity. Vitamin D deficiency has also been described as pandemic, especially in the Europe. Regardless of age, ethnicity, and latitude; recent data showed that 40% of the Europeans are vitamin D deficient (25(OH)D levels <50 nmol/L), and 13% are severely deficient (25(OH)D <30 nmol/L)
A quadratic relationship was found between the prevalences of vitamin D deficiency in most commonly affected countries by COVID-19 and the latitudes.
   Note: This equation does not appear to be in the text
Vitamin D deficiency is more common in the subtropical and midlatitude countries than the tropical and high latitude countries.
The most commonly affected countries with severe vitamin D deficiency are from the subtropical (Saudi Arabia; 46%, Qatar; 46%, Iran; 33.4%, Chile; 26.4%) and midlatitude (France; 27.3%, Portugal; 21.2% and Austria; 19.3%) regions.
Severe vitamin D deficiency was found to be nearly 0% in some high latitude countries (e.g. Norway, Finland, Sweden, Denmark and Netherlands).
Accordingly, we would like to call attention to the possible association between severe vitamin D deficiency and mortality pertaining to COVID-19. Given its rare side effects and relatively wide safety, prophylactic vitamin D supplementation and/or food fortification might reasonably serve as a very convenient adjuvant therapy for these two worldwide public health problems alike.


References

  1. Coronavirus disease (COVID-2019) situation reports. Geneva: World Health Organization, 2020 (https://www.who.int/emergencies/diseases/novel-coronavirus- 2019/situation-reports/. opens in new tab). Last accessed on 2020 May 4.
  2. Yuki K, Fujiogi M, Koutsogiannaki S. COVID-19 pathophysiology: A review. Clin Immunol. 2020:108427. doi: 10.1016/j.clim.2020.108427.
  3. Vaduganathan M, Vardeny O, Michel T, McMurray JJV, Pfeffer MA, Solomon SD. Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19. N Engl J Med. 2020;382:1653-9.
  4. Zou X, Chen K, Zou J, Han P, Hao J, Han Z. Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Front Med. 2020 (In Press). doi: 10.1007/s11684- 020-0754-0.
  5. Eymundsdottir H, Chang M, Geirsdottir OG, et al. Lifestyle and 25-hydroxy-vitamin D among community-dwelling old adults with dementia, mild cognitive impairment, or normal cognitive function. Aging Clin Exp Res. 2020 (In Press) doi:10.1007/s40520-020-01531-1.
  6. Lopes JB, Fernandes GH, Takayama L, et al. A predictive model of vitamin D insufficiency in older community people: from the Sao Paulo aging & health study (SPAH). Maturitas. 2014; 78: 335-40.
  7. Sarafin K, Durazo-Arvizu R, Tian L, et al. Standardizing 25-hydroxyvitamin D values from the Canadian Health Measures Survey. Am J Clin Nutr. 2015; 102: 1044-50. Downloaded from https://www.cambridge.org/core. IP address: 24.113.174.250, on 13 May 2020 at 11:06:48, subject to the Cambridge Core terms of use, available at https://www.cambridge.org/core/terms. https://doi.org/10.1017/S0007114520001749
  8. Urrunaga-Pastor D, Guarnizo-Poma M, Macollunco-Flores P, et al. Association between vitamin D deficiency and insulin resistance markers in euthyroid nondiabetic individuals. Diabetes Metab Syndr. 2019; 13: 258-63.
  9. Orces CH. Vitamin D status among older adults residing in the littoral and Andes mountains in Ecuador. ScientificWorldJournal 2015; 2015: 545297.
  10. Clark P, Vivanco-Munoz N, Pina JT, et al. High prevalence of hypovitaminosis D in Mexicans aged 14 years and older and its correlation with parathyroid hormone. Arch Osteoporos. 2015; 10: 225.
  11. Solis-Urra P, Cristi-Montero C, Romero-Parra J, et al. Passive commuting and higher sedentary time is associated with vitamin D deficiency in adult and older women: Results from Chilean National Health Survey 2016-2017. Nutrients. 2019; 11: 300.
  12. Formiga F, Ferrer A, Megido MJ, et al. Low serum vitamin D is not associated with an increase in mortality in oldest old subjects: the Octabaix three-year follow-up study. Gerontology. 2014; 60: 10-5.
  13. Veronese N, Sergi G, De Rui M, et al. Serum 25-hydroxyvitamin D and incidence of diabetes in elderly people: the PRO.V.A. study. J Clin Endocrinol Metab. 2014; 99: 2351-8.
  14. Aspell N, Laird E, Healy M, et al. The prevalence and determinants of vitamin D status in community-dwelling older adults: Results from the English Longitudinal Study of Ageing (ELSA). Nutrients. 2019; 11: 1253.
  15. Cougnard-Gregoire A, Merle BM, Korobelnik JF, et al. Vitamin D deficiency in community-dwelling elderly Is not associated with age-related macular degeneration. J Nutr. 2015; 145: 1865-72.
  16. Vetter VM, Spira D, Banszerus VL, et al. Epigenetic clock and leukocyte telomere length are associated with vitamin D status, but not with functional assessments and frailty in the Berlin Aging Study II. J Gerontol A Biol Sci Med Sci. 2020 (In Press) doi:10.1093/gerona/glaa101
  17. Karonova T, Andreeva A, Nikitina I, et al. Prevalence of vitamin D deficiency in the North-West region of Russia: A cross-sectional study. J Steroid Biochem Mol Biol. 2016; 164: 230-4.
  18. Ozturk ZA, Gol M, Turkbeyler JR. Prevalence of vitamin D deficiency in otherwise healthy individuals between the ages of 18 and 90 years in southeast Turkey. Wien Klin Wochenschr. 2017; 129: 854-5.
  19. Hoge A, Donneau AF, Streel S, et al. Vitamin D deficiency is common among adults in Wallonia (Belgium, 51°30' North): findings from the Nutrition, Environment and Cardio-Vascular Health study. Nutr Res. 2015; 35: 716-25.
  20. Ten Haaf DSM, Balvers MGJ, Timmers S, et al. Determinants of vitamin D status in physically active elderly in the Netherlands. Eur J Nutr. 2019; 58: 3121-8.
  21. Sakem B, Nock C, Stanga Z, et al. Serum concentrations of 25-hydroxyvitamin D and immunoglobulins in an older Swiss cohort: results of the Senior Labor Study. BMC Med. 2013; 11: 176.
  22. Duarte C, Carvalheiro H, Rodrigues AM, et al. Prevalence of vitamin D deficiency and its predictors in the Portuguese population: a nationwide population-based study. Arch Osteoporos. 2020; 15: 36.
  23. Buchebner D, McGuigan F, Gerdhem P, et al. Vitamin D insufficiency over 5 years is associated with increased fracture risk-an observational cohort study of elderly women. Osteoporos Int. 2014; 25: 2767-75.
  24. Cashman KD, Kiely M, Kinsella M, et al. Evaluation of vitamin D standardization program protocols for standardizing serum 25-hydroxyvitamin D data: a case study of the program’s potential for national nutrition and health surveys. Am J Clin Nutr.
  25. Elmadfa I, Meyer AL, Wottawa D, et al. Vitamin D intake and status in Austria and its effects on some health indicators. Austin J Nutr Metab. 2017; 4: 1050.
  26. Pludowski P, Ducki C, Konstantynowicz J, et al. Vitamin D status in Poland. Pol Arch Med Wewn. 2016; 126: 530-9.
  27. Niculescu DA, Capatina CAM, Dusceac R, et al. Seasonal variation of serum vitamin D levels in Romania. Arch Osteoporos. 2017; 12: 113.
  28. Cashman KD, Dowling KG, Skrabakova Z, et al. Standardizing serum 25- hydroxyvitamin D data from four Nordic population samples using the vitamin D standardization program protocols: Shedding new light on vitamin D status in Nordic individuals. Scand J Clin Lab Invest. 2015; 75: 549-61.
  29. Cashman KD, Dowling KG, Skrabakova Z, et al. Vitamin D deficiency in Europe: pandemic? Am J Clin Nutr. 2016; 103: 1033-44.
  30. Kassi EN, Stavropoulos S, Kokkoris P, et al. Smoking is a significant determinant of low serum vitamin D in young and middle-aged healthy males. Hormones (Athens). 2015; 14: 245-50.
  31. Laktasic-Zerjavic N, Korsic M, Crncevic-Orlic Z, et al. Vitamin D status, dependence on age, and seasonal variations in the concentration of vitamin D in Croatian postmenopausal women initially screened for osteoporosis. Clin Rheumatol. 2010; 29: 861-7.
  32. Wei J, Zhu A, Ji JS. A comparison study of vitamin D deficiency among older adults in China and the United States. Sci Rep. 2019; 9: 19713.
  33. Robien K, Butler LM, Wang R, et al. Genetic and environmental predictors of serum 25-hydroxyvitamin D concentrations among middle-aged and elderly Chinese in Singapore. Br J Nutr. 2013; 109: 493-502.
  34. Nakamura K, Kitamura K, Takachi R, et al. Impact of demographic, environmental, and lifestyle factors on vitamin D sufficiency in 9084 Japanese adults. Bone. 2015; 74: 10-7.
  35. Shin JH, Lee HT, Lim YH, et al. Defining vitamin D deficiency and its relationship to hypertension in postmenopausal Korean women. J Women’s Health (Larchmt). 2015; 24: 1021-9.
  36. Gill TK, Hill CL, Shanahan EM, et al. Vitamin D levels in an Australian population. BMC Public Health. 2014; 14 :1001.
  37. Chin KY, Ima-Nirwana S, Ibrahim S, et al. Vitamin D status in Malaysian men and its associated factors. Nutrients. 2014; 6: 5419-33.
  38. Khosravi-Boroujeni H, Sarrafzadegan N, Sadeghi M, et al. Prevalence and trends of vitamin D deficiency among Iranian adults: A longitudinal study from 2001-2013. J Nutr Sci Vitaminol (Tokyo). 2017; 63: 284-90.
  39. Alfawaz H, Tamim H, Alharbi S, et al. Vitamin D status among patients visiting a tertiary care center in Riyadh, Saudi Arabia: a retrospective review of 3475 cases. BMC Public Health 2014; 14: 159.
  40. Mehboobali N, Iqbal SP, Iqbal MP. High prevalence of vitamin D deficiency and insufficiency in a low income peri-urban community in Karachi. J Pak Med Assoc. 2015; 65: 946-9.
  41. Saliba W, Rennert HS, Kershenbaum A, et al. Serum 25(OH)D concentrations in sunny Israel. Osteoporos Int. 2012; 23: 687-94.
  42. El-Menyar A, Rahil A, Dousa K, et al. Low vitamin d and cardiovascular risk factors in males and females from a sunny, rich country. Open Cardiovasc Med J. 2012; 6:
  43. Mechenro J, Venugopal G, Buvnesh Kumar et al. Vitamin D status in Kancheepuram District, Tamil Nadu, India. BMC Public Health. 2018; 18: 1345.
  44. Lips P, Cashman KD, Lamberg-Allardt C, et al. Current vitamin D status in European and Middle East countries and strategies to prevent vitamin D deficiency: a position statement of the European Calcified Tissue Society. Eur J Endocrinol. 2019; 180: P23-P54.
  45. Mendes MM, Hart KH, Botelho PB, Lanham SA. Vitamin D status in the tropics: is sunlight exposure the main determinant? Nutr Bull 2018;43:428-34
  46. Schleicher RL, Sternberg MR, Looker AC, et al. National estimates of serum total 25– hydroxyvitamin D and metabolite concentrations measured by liquid chromatography-tandem mass spectrometry in the US population during 2007-2010. J Nutr. 2016; 146: 1051-61.
  47. Grant WB, Lahore H, McDonnell SL, Baggerly CA, French CB, Aliano JL, Bhattoa HP. Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths. Nutrients. 2020;12.pii: E988. doi: 10.3390/nu12040988.
  48. Beard JA, Bearden A, Striker R. Vitamin D and the anti-viral state. J Clin Virol. 2011; 50: 194-200.
  49. Feldman D, Pike JW, Bouillon R, Giovannucci E, Goltzman D, Hewison M. (Eds.). (2017). Vitamin D: Volume 1: Biochemistry, Physiology and Diagnostics. Academic Press.
  50. Sajadi MM, Habibzadeh P, Vintzileos A, Shokouhi S, Shervin and Miralles-Wilhelm, F, Amoroso A. Temperature, humidity and latitude analysis to predict potential spread and seasonality for COVID-19 (March 5, 2020). Available at
  51. SSRN: https://ssrn.com/abstract=3550308 or http://dx.doi.org/10.2139/ssrn.3550308
  52. Welch D, Buonanno M, Grilj V, et al. Far-UVC light: A new tool to control the spread of airborne-mediated microbial diseases. Sci Rep. 2018; 8: 2752.
  53. Novel coronavirus pneumonia emergency response epidemiology team. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Zhonghua Liu Xing Bing Xue Za Zhi 2020; 41: 145-51.
  54. Alipio, Mark, Vitamin D supplementation could possibly improve clinical outcomes of patients infected with Coronavirus-2019 (COVID-2019) (April 9, 2020). Available at SSRN: https://ssrn.com/abstract=3571484 or http://dx.doi.org/10.2139/ssrn.3571484.
  55. Martineau AR, Jolliffe DA, Hooper RL, et al. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ. 2017;356:i6583
  56. Mostafa WZ, Hegazy RA. Vitamin D and the skin: Focus on a complex relationship: A review. J Adv Res. 2015;6:793-804.

COVID-19 treated by Vitamin D - studies, reports, videos (in VitaminDWiki)

5 most-recently changed Virus entries


Created by admin. Last Modification: Sunday August 29, 2021 21:30:03 GMT-0000 by admin. (Version 11)

Attached files

ID Name Comment Uploaded Size Downloads
13810 Strabismus map.jpg admin 13 May, 2020 81.86 Kb 998
13809 Strabismus.jpg admin 13 May, 2020 91.20 Kb 5022
13808 Scientific Strabismus.pdf admin 13 May, 2020 1.39 Mb 658